CAPR - Capricor Therapeutics, Inc. So'nggi... | Finranks

12.08.2026

Bronstein, Gewirtz & Grossman LLC Urges Capricor Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

New class action for Capricor (CAPR) urges investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 9/28/2026

12.08.2026

Kaplan Fox Alerts Investors of Capricor Therapeutics, Inc. (NASDAQ: CAPR) with Significant Losses to a Securities Class Action Deadline on September 28, 2026

NEW YORK, Aug. 12, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Capricor Therapeutics, Inc. (“Capricor” or the “Company”) (NASDAQ: CAPR) on behalf of investors that purchased or otherwise acquired Capricor securities between December 17, 2025 and July 26, 2026 (the “Class Period”). CLICK HERE TO JOIN THE CASE If you are an investor in Capricor and have suffered losses, you may CLICK HERE to contact us.

12.08.2026

CAPR CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Capricor Investors of Securities Class Action Lawsuit Deadline on September 29, 2026

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Capricor To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Capricor between December 17, 2025 and July 26, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - August 12, 2026) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Capricor Therapeutics, Inc. (""Capricor" or the "Company") (NASDAQ: CAPR) and reminds investors of the September 29, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

12.08.2026

CAPR UPCOMING DEADLINE: Levi & Korsinsky Alerts Capricor Therapeutics, Inc. Stockholders of Securities Class Action - Contact the Firm

Capricor Therapeutics shares collapsed from $19.70 to $4.19 following FDA briefing documents and an adverse advisory committee vote, falling an aggregate 15.08 per share across two corrective-disclosures, or 78.7%, according to allegations in a pending securities class action. NEW YORK, Aug. 12, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP alerts investors in Capricor Therapeutics, Inc. (NASDAQ: CAPR) that a securities class action has been filed on behalf of shareholders who purchased securities between December 17, 2025 and July 26, 2026.

12.08.2026

CAPRICOR THERAPEUTICS, INC. INVESTORS WITH LOSSES HAVE UNTIL SEPTEMBER 28, 2026 TO JOIN SECURITIES CLASS ACTION – Bernstein Liebhard LLP Announces Deadline

NEW YORK, Aug. 12, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Capricor Therapeutics, Inc. (“Capricor” or the “Company”) (NASDAQ: CAPR) of the September 28, 2026 deadline involving a securities fraud class action lawsuit commenced against the Company. Should You Join The Capricor Class Action Lawsuit : Do you, or did you, own shares of Capricor Therapeutics, Inc. (NASDAQ: CAPR)?

12.08.2026

Kaplan Fox Notifies Capricor Therapeutics, Inc. (CAPR) Investors of a Securities Class Action Deadline on September 28, 2026

New York, New York--(Newsfile Corp. - August 12, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Capricor Therapeutics, Inc. ("Capricor" or the "Company") (NASDAQ: CAPR) on behalf of investors that purchased or otherwise acquired Capricor securities between December 17, 2025 and July 26, 2026 (the "Class Period"). CLICK HERE TO JOIN THE CASE If you are an investor in Capricor and have suffered losses, you may CLICK HERE to contact us.

12.08.2026

CAPR Securities Lawsuit: Capricor Therapeutics Securities Fraud Class Action is Pending – Contact BFA Law before September 28 if You Lost Money after the 64% Stock Drop

NEW YORK, Aug. 12, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Capricor Therapeutics, Inc. (NASDAQ:CAPR) and certain of the company's senior executives for securities fraud after its significant stock drop resulting from potential violations of the federal securities laws. If you invested in Capricor Therapeutics securities, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/capricor-class-action-lawsuit.

Videolar

No Data

There is no data to display

Reytinglar oshishi / pasayishi

Ticker	Tashkilot	Reyting o‘zgarishi	Maqsadli narx	Sana
CAPR	Maxim Group	Hold	undefined >> undefined	July 30th 2026
CAPR	Cantor Fitzgerald	Neutral	undefined >> $4	July 30th 2026
CAPR	Oppenheimer	Perform	undefined >> undefined	July 30th 2026
CAPR	Piper Sandler	Neutral	undefined >> $2	July 30th 2026
CAPR	H.C. Wainwright	Neutral	undefined >> undefined	July 30th 2026
CAPR	Ladenburg Thalmann	Neutral	undefined >> undefined	July 30th 2026

Press-relizlar

12.08.2026

Bronstein, Gewirtz & Grossman LLC Urges Capricor Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

New class action for Capricor (CAPR) urges investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 9/28/2026

Capricor Therapeutics, Inc. (CAPR)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Capricor Therapeutics, Inc. (CAPR)

Bronstein, Gewirtz & Grossman LLC Urges Capricor Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

Kaplan Fox Alerts Investors of Capricor Therapeutics, Inc. (NASDAQ: CAPR) with Significant Losses to a Securities Class Action Deadline on September 28, 2026

CAPR CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Capricor Investors of Securities Class Action Lawsuit Deadline on September 29, 2026

CAPR UPCOMING DEADLINE: Levi & Korsinsky Alerts Capricor Therapeutics, Inc. Stockholders of Securities Class Action - Contact the Firm

CAPRICOR THERAPEUTICS, INC. INVESTORS WITH LOSSES HAVE UNTIL SEPTEMBER 28, 2026 TO JOIN SECURITIES CLASS ACTION – Bernstein Liebhard LLP Announces Deadline

Kaplan Fox Notifies Capricor Therapeutics, Inc. (CAPR) Investors of a Securities Class Action Deadline on September 28, 2026

CAPR Securities Lawsuit: Capricor Therapeutics Securities Fraud Class Action is Pending – Contact BFA Law before September 28 if You Lost Money after the 64% Stock Drop

Videolar

No Data

Reytinglar oshishi / pasayishi

Press-relizlar

Bronstein, Gewirtz & Grossman LLC Urges Capricor Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

Kaplan Fox Alerts Investors of Capricor Therapeutics, Inc. (NASDAQ: CAPR) with Significant Losses to a Securities Class Action Deadline on September 28, 2026

CAPR CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Capricor Investors of Securities Class Action Lawsuit Deadline on September 29, 2026

CAPR UPCOMING DEADLINE: Levi & Korsinsky Alerts Capricor Therapeutics, Inc. Stockholders of Securities Class Action - Contact the Firm

Search stocks

Capricor Therapeutics, Inc. (CAPR)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Capricor Therapeutics, Inc. (CAPR)

Bronstein, Gewirtz & Grossman LLC Urges Capricor Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

Kaplan Fox Alerts Investors of Capricor Therapeutics, Inc. (NASDAQ: CAPR) with Significant Losses to a Securities Class Action Deadline on September 28, 2026

CAPR CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Capricor Investors of Securities Class Action Lawsuit Deadline on September 29, 2026

CAPR UPCOMING DEADLINE: Levi & Korsinsky Alerts Capricor Therapeutics, Inc. Stockholders of Securities Class Action - Contact the Firm

CAPRICOR THERAPEUTICS, INC. INVESTORS WITH LOSSES HAVE UNTIL SEPTEMBER 28, 2026 TO JOIN SECURITIES CLASS ACTION – Bernstein Liebhard LLP Announces Deadline

Kaplan Fox Notifies Capricor Therapeutics, Inc. (CAPR) Investors of a Securities Class Action Deadline on September 28, 2026

CAPR Securities Lawsuit: Capricor Therapeutics Securities Fraud Class Action is Pending – Contact BFA Law before September 28 if You Lost Money after the 64% Stock Drop

Videolar

No Data

Reytinglar oshishi / pasayishi

Press-relizlar

Bronstein, Gewirtz & Grossman LLC Urges Capricor Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

Kaplan Fox Alerts Investors of Capricor Therapeutics, Inc. (NASDAQ: CAPR) with Significant Losses to a Securities Class Action Deadline on September 28, 2026

CAPR CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Capricor Investors of Securities Class Action Lawsuit Deadline on September 29, 2026

CAPR UPCOMING DEADLINE: Levi & Korsinsky Alerts Capricor Therapeutics, Inc. Stockholders of Securities Class Action - Contact the Firm